[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 27, 1985

FROM THE FDA

JAMA. 1985;254(24):3409. doi:10.1001/jama.1985.03360240019004

(Editor's Note: Written inquiries may be directed to the Office of Health Affairs, FDA, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857.)

×